| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 08/04/2005 | WO2004092135A3 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 08/04/2005 | WO2004076417A9 Novel crystalline forms of trandolapril |
| 08/04/2005 | US20050171186 3-(1',2'-Dihydro-2'-thioxospiro[cyclohexane-1,3'-[3H]indol]-5'-yl)benzonitrile; 5'-(5-Cyano-1-methyl-1H-pyrrol-2-yl)spiro[cyclohexane-1,3'-[3H]indol]-2'-ylidenecyanamide; progesterone receptor agonist; mixture with estrone (estrogen); hormone replacement therapy, contraception; anticarcinogenic |
| 08/04/2005 | US20050171185 Indole derivatives |
| 08/04/2005 | US20050171183 Indole-type inhibitors of p38 kinase |
| 08/04/2005 | US20050171181 Histamine-3 receptor modulators |
| 08/04/2005 | US20050171178 Exo-1-methyl-1H-imidazole-4-sulfonic acid {3-[6-ethyl-3-(2-hydroxy-indan-2-ylmethyl)-3-aza-bicyclo[3.1.0]hex-6-yl]-phenyl}-amide; opioid receptors (mu, kappa and delta) antagonists; not substrate of the variable enzyme CYP2D6; addiction to an opiates, alcohol; obesity |
| 08/04/2005 | US20050171146 Non-peptidic BRS-3 agonists |
| 08/04/2005 | US20050171143 selective Chemoattractant receptor-homologous molecule expressed on Th2 cells ( CRTH2 receptor) antagonist; activities for eosinphil and basophil infiltration; indol/carbazol-sulfonamide derivatives; antiallergenic agent; asthma, allergic rhinitis and dermatitis, polyarteritis, autoimmune disease |
| 08/04/2005 | US20050171136 Modulators of the glucocorticoid receptor and method |
| 08/04/2005 | US20050171118 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis |
| 08/04/2005 | US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders |
| 08/04/2005 | US20050171109 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 08/04/2005 | US20050171104 Novel thyroid receptor ligands |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 08/04/2005 | US20050169844 Near infrared imaging agent |
| 08/04/2005 | CA2553986A1 Adjuvant compositions |
| 08/04/2005 | CA2553966A1 Vanilloid receptor ligands and their use in treatments |
| 08/04/2005 | CA2553831A1 Diamino alcohols and their use as renin inhibitors |
| 08/04/2005 | CA2552781A1 Indol-alanine derivatives as selective s1p4-agonists |
| 08/03/2005 | EP1559718A1 Combretastatin A-4 phosphate prodrug salts with nitrogen-containing compounds |
| 08/03/2005 | EP1559710A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use |
| 08/03/2005 | EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 08/03/2005 | EP1559422A1 Receptor function controlling agent |
| 08/03/2005 | EP1559374A1 Cyanine dyes |
| 08/03/2005 | EP1558608A1 Oxindole substituted piperazine derivatives |
| 08/03/2005 | EP1558575A1 Process for preparation of carvedilol |
| 08/03/2005 | EP1558567A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 08/03/2005 | EP1558565A2 Halogenated selective androgen receptor modulators and methods of use thereof |
| 08/03/2005 | EP1558253A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 08/03/2005 | CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
| 08/03/2005 | CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 08/03/2005 | CN1649840A Non-peptidic BRS-3 agonists |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1649827A Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids |
| 08/03/2005 | CN1649820A Compounds that modulate PPAR activity and methods for their preparation |
| 08/03/2005 | CN1649819A Novel thyroid receptor ligands |
| 08/03/2005 | CN1649612A Induction method for cell differentiation |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1648128A Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine |
| 08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
| 08/03/2005 | CN1213036C Novel amide derivatives |
| 08/03/2005 | CN1213029C S-Ht receptor agonist and its preparing method for salt |
| 08/03/2005 | CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
| 08/03/2005 | CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/02/2005 | US6924377 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid |
| 08/02/2005 | US6924312 Taxol enhancer compounds |
| 08/02/2005 | US6924310 Sulfur compounds such as N-[3,5-dichloro-4-(3-cyclopropylsulfamoyl-4-hydroxy-phenoxy)-phenyl]-malonamic acid, used as anoroexigenic, antiarrhythmia, hypotensive or antidiabetic agents; alopecia |
| 08/02/2005 | US6924304 Compounds such as N-((dimethylamino)acetyl)-1-methyl-N-(3, 4,5-trimethoxyphenyl)-1H-indole-5-sulfonamide for therapy of cancer |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 08/02/2005 | US6924281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 08/02/2005 | US6924251 herbicides. |
| 08/02/2005 | CA2321639C Bicyclo[2.2.1]heptanes and related compounds |
| 08/02/2005 | CA2254972C Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 08/02/2005 | CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities |
| 07/28/2005 | WO2005068490A1 Inclusion complexes of perindopril |
| 07/28/2005 | WO2005068425A1 New crystalline form of perindopril |
| 07/28/2005 | WO2005068424A1 Indolinone derivatives as receptor tyrosine kinase ihibitors |
| 07/28/2005 | WO2005068423A1 Malononitrile compound and use thereof |
| 07/28/2005 | WO2005068422A2 Process for crystallization of ramipril and preparation of a hydrated form thereof |
| 07/28/2005 | WO2005068415A1 Phenylalanine derivative |
| 07/28/2005 | WO2005068413A1 Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound |
| 07/28/2005 | WO2005067923A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 07/28/2005 | WO2005067922A1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride |
| 07/28/2005 | WO2005016875A3 Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein kinase inhibitors |
| 07/28/2005 | WO2005002523A3 Process for preparing highly pure and free-flowing solid of 7-ethyltryptophol |
| 07/28/2005 | WO2004098498A3 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 07/28/2005 | US20050165256 Aminating compounds such as 3,5-dichloroaniline in the presence of ammonia and a catalyst selected from the group consisting of copper salts, cupric and cuprous oxides and mixtures, heating and pressurization |
| 07/28/2005 | US20050165114 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents; AP-1 activation inhibitor, NF-kappa B activation inhibitor |
| 07/28/2005 | US20050165085 Polymorphic forms of tegaserod base and salts thereof |
| 07/28/2005 | US20050165084 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; treating coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; atorvastatin 4-(nitrooxy)butyl ester |
| 07/28/2005 | US20050165083 Hydroisoindoline tachykinin receptor antagonists |
| 07/28/2005 | US20050165055 Novel substituted indoles |
| 07/28/2005 | US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide |
| 07/28/2005 | US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides |
| 07/28/2005 | US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides |
| 07/28/2005 | US20050164872 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 07/28/2005 | US20050164868 Non-heating clay composites for building materials |
| 07/28/2005 | US20050163715 Dynamic organ function monitoring agents |
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/28/2005 | CA2554199A1 Process for crystallization of ramipril and preparation of a hydrated form thereof |
| 07/28/2005 | CA2552953A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 07/28/2005 | CA2552740A1 Indolylmaleimde derivatives as pkc inhibitors |
| 07/28/2005 | CA2552738A1 Indolylmaleimide derivatives |
| 07/28/2005 | CA2548982A1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride |
| 07/28/2005 | CA2547696A1 Malononitrile compounds and use thereof |
| 07/27/2005 | EP1556382A1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 07/27/2005 | EP1556348A1 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists |
| 07/27/2005 | EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 07/27/2005 | EP1556037A1 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity |
| 07/27/2005 | EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 07/27/2005 | EP1556034A1 Indole derivatives as beta-2 agonists |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | CN1646522A Processes for producing indole compound |
| 07/27/2005 | CN1646456A Novel aromatic compound and organic electroluminescnet element containing the same |
| 07/27/2005 | CN1646446A Non-heating clay composites for building materials |
| 07/26/2005 | US6921835 Carbocyclic carboxy amines such as 1-aminomethyl-3,4-dimethyl-cyclopentyl acetic acid or prodrugs used as antiepileptics, antidepressants, anxiolytics, analgesics, antiinflammatory agents and for prophylaxis of neurodegenerative disorders |